Why DYN? Dyne Therapeutics, Inc. Analysis, Price & AI Insights | Whystock
DYN
$17.39-0.16 (-0.91%)
Pre-Market$16.90-0.49 (-2.82%)· Last close May 1
Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States.